Analyst Biographies

David W. Miller is a Managing Director at Caris & Company covering the Media and Entertainment Industries, and is focused on several sub-segments within the sector, including film exhibition, digital cinema, broadcasting and cable television, theme parks, entertainment licensing, radio, outdoor media, Hispanic media and emerging technologies. Prior to joining Caris, Mr. Miller was a Managing Director and Senior Research Analyst at Sanders Morris Harris Group, based in Los Angeles. While at SMH, and in 2003, Mr. Miller was ranked #1 by Institutional Investor Magazine for the media sector among boutique/regional firms. Prior to SMH, Mr. Miller was a Vice President covering the Media/Entertainment sector at Sutro & Co., also in Los Angeles. Mr. Miller has held a variety of position throughout multiple industries, including notable roles at the Walt Disney Company and Texaco, Inc.

Mr. Miller graduated from Northwestern University in 1990 with a Bachelor of Science in Communications and Political Science, and holds an M.B.A. from the University of Chicago, where he graduated in 1997. Mr. Miller holds the 7, 63, 86 and 87 securities registrations.

David Moskowitz, RPh., joined Caris & Company as a Managing Director of Healthcare Research at Caris and writes on the pharmaceutical industry. Prior to joining Caris, Mr. Moskowitz was Group Head of Healthcare Research at FBR Capital Markets, where he led the build-out of FBR's healthcare research platform and provided coverage on the large cap pharmaceutical industry and select specialty pharmaceutical companies. Mr. Moskowitz also spent time at FBR in investment banking, rebuilding the healthcare team. Prior to FBR, he worked for UBS Warburg as a specialty pharmaceuticals analyst, and before that, he was a biotechnology analyst for Standard and Poor's. Mr. Moskowitz practiced as a registered pharmacist in various hospital and retail settings before entering the financial services industry.

Mr. Moskowitz received his B.S. in pharmacy from Rutgers University and his M.B.A. in finance and pharmaceutical industry studies from Fairleigh Dickinson University.

James Molloy joins Caris & Company from Oppenheimer & Company where he was a Vice President covering the specialty pharmaceutical sector. While at Oppenheimer Mr. Molloy led the build-out of Oppenheimer’s specialty pharmaceutical research platform and spearheaded the development of Oppenheimer’s Physician Diner Series, matching investors with specialists in the healthcare field. Mr. Molloy was ranked #3 in the pharmaceutical sector by Forbes.com/StarMine for earnings estimate accuracy during 2007, and he brings 10 years of sell-side experience. Prior to Oppenheimer Mr. Molloy covered specialty pharmaceuticals, biotech, and selective medical device companies at Leerink Swann & Company.

Mr. Molloy earned a Bachelor of Arts degree from University of Colorado, Boulder, and an M.B.A. from the FW Olin Graduate School of Business at Babson College. He holds the Series 7, 63, 86 and 87 licenses.

Christopher Warren has been a senior analyst since 2005, first at Janney Montgomery Scott, SunTrust Robinson Humphrey, and most recently at FBR Capital Markets. Prior to becoming a senior analyst, he spent four years as an equity research associate. His primary areas of focus are device manufacturers serving the cardiovascular, respiratory, and tissue regeneration markets.

Mr. Warren concentrates his research efforts on information channels, typically organized around a class of physician. The corresponding information flow has been helpful in formulating investment theses and trading calls in stocks of device manufacturers catering to interventional cardiologists, interventional radiologists, vascular/general surgeons, and pulmonologists/sleep physicians.

Mr. Warren received his bachelor’s degree from Williams College. He is licensed with a 7, 63, 86 and 87.

Mr. Carpio is a Senior Research Analyst covering the Health Care Information Technology and Services sector. Mr. Carpio joins Caris & Company from Prudential Equity Group, LLC, where he spent seven years covering numerous healthcare sectors including Healthcare Facilities, Managed Care, and Pharmacy Benefit Managers. Prior to serving as senior Healthcare IT analyst, Mr. Carpio was an Associate Analyst on the Prudential Healthcare Research team.

Before joining Prudential, Mr. Carpio worked at MetLife, where his coverage extended to consumer, commercial, and mortgage finance companies. Previously, Mr. Carpio was an Associate in Merrill Lynch’s Finance Department. Mr. Carpio began his career with GE Capital in the municipal finance insurance division – Financial Guaranty Insurance Company (FGIC).

Mr. Carpio holds a B.A. in Management from The University of Pennsylvania, Wharton School and an M.B.A. in Corporate Strategy & Finance from the University of Michigan with honors. He holds the Series 7, 63, 86 and 87 licenses.

Mr. Khurshid joins Caris & Company from Pacific Growth Equities where he was the Research Analyst covering the Life Science Tools & Dx sector. Prior to his tenure at Pacific Growth Equities, Mr. Khurshid spent over 2 1/2 years with Cytokinetics as a Research Associate in the Assay Development group. Previously, Mr. Khurshid worked at Aurora Biosciences (acquired by Vertex) as an Associate Bioengineer developing software for the Company's high throughput screening system.

Mr. Khurshid holds a B.S. in Bioengineering and B.A. in Economics from the University of California, San Diego and holds the Series 7, 63, 86 and 87 securities registrations.

Ms. Kohler brings to Caris & Company nineteen years of experience as an energy analyst. Most recently, Ms. Kohler was a Senior Analyst at Dahlman Rose & Co. where she focused on the independent refining sector. Ms. Kohler started her Wall Street research experience at Salomon Brothers in 1990. Her other experiences includes senior research positions at Kidder, Peabody, where she was responsible for the domestic and international integrated oil firms and the independent refiners, and UBS Securities, where she covered the independent refiners and fertilizer companies. She also worked at several boutique sell-side firms, including IRG Research, Gilford Securities and HD Brous, where her coverage of the energy universe included integrated oils, independent refiners, specialty chemical, oilfield service and maritime shipping companies.

Ms. Kohler graduated from Wheaton College with a B.A. in economics. She holds the Series 7, 63, 86 and 87 Securities registrations.

Mrs. Gallacher has been with Caris & Company since 2003 covering Action Sports Retailers, Specialty Retail, and Home Furnishing Retail companies. Mrs. Gallacher joined Caris & Company from Banc of America Securities, where she spent four years as an Associate Analyst in the firm's prestigious retail group. At Banc of America, Mrs. Gallacher covered the home furnishings retail industry and broad-line retailing. Ms. Gallacher's in-depth qualitative and quantitative analysis skills earned her street wide recognition for her inventive and thorough research. Prior to joining Banc of America Securities, Mrs. Gallacher worked for Institutional Investor's #1 ranked beverage analyst as a research associate at PaineWebber. She holds a bachelors degree in economics from the University of California, Los Angeles. Ms. Gallacher holds the Series 7, 63, 86 and 87 securities registrations.

Ms. Bolton Weiser brings to Caris & Company over 15 years of experience as an equity research analyst. Prior to joining the firm, she was a senior equity analyst at Oppenheimer & Co. Inc. for over seven years, where she covered the Household Products; Personal Care/Cosmetics sector, as well as Toys. She was ranked #2 in the Wall Street Journal “Best on the Street” survey for stock selection in her sector in 2003 and 2006, and was also named the top Household Products analyst by Bloomberg Markets magazine in 2005, based on S&P 500 stock selection. Ms. Bolton Weiser was named the #1 Stock Picker in Personal Products and #3 Earnings Estimator in Household Products in May 2006, and the #1 Earnings Estimator in Personal Products in May 2007 by Forbes.com. In 2003, she was named “Best Up-and-Coming Analyst” in her sector by Institutional Investor magazine.

From 1992 to 2000, Ms. Bolton Weiser was a buy-side equity analyst at AllianceBernstein, where she followed stocks in the industrial and consumer sectors. From 1998 to 2000, she was Portfolio Manager of the Alliance Global Environment Fund.

Ms. Bolton Weiser holds an M.B.A. in Finance and Marketing from the University of Chicago, and a B.A. degree in Biochemistry from Wellesley College. She holds the Series 7, 63, 86, and 87 securities registrations.